Combinations of inhibin with bronchodilators
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ASTRAZENECA AB
- Publication Date
- 2007-06-20
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The present invention provides medicaments for the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) comprising combinations of bronchodilators, glucocorticosteroids and HMG-CoA reductase inhibitors. Background technique
[0002] The diagnosis and treatment of many diseases focus, for obvious reasons, on the typical criteria and manifestations that are characteristic of a particular disease (thereby distinguishing it from other diseases). Examples are joint-related signs and symptoms in rheumatoid arthritis (RA), and lung function tests in COPD.
[0003] But many diseases have significant co-morbidity, and they are often considered "other" diseases because they are not unique to or specific to the primary disease. For example, cardiovascular co-morbidities may often be considered indeterminate and not directly related to primary diseases such as RA or COPD. However, co-morbidities can be as important as regular ma...